A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 93, Issue 2, 1999, Pages 185-188

  Van Dillen, J ^a,b   Custers, M ^a,b   Wensink, A ^b,c   Wouters, B ^a,b   Van Voorthuizen, T ^b,c   Voorn, W ^a   Khan, B ^d   Muller, L ^a   Nevill, C ^b,e  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b AMREF HEALTH AFRICA   (Kenya)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^e Newtown Medical Practice   (United Kingdom)

Author keywords

Amodiaquine; Chemotherapy; Clinical trial; Kenya; Malaria; Plasmodium falciparum; Sulfadoxine pyrimethamine

Indexed keywords

AMODIAQUINE; FANSIDAR; PYRIMETHAMINE; SULFADOXINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; KENYA; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MULTICENTER STUDY; PLASMODIUM FALCIPARUM; RANDOMIZED CONTROLLED TRIAL;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032903234     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(99)90304-8     Document Type: Article

References (20)

1. Anonymous (1992). Epidemic of CQ resistant malaria in North Eastern Kenya 1992. Nairobi: Catholic Diocese of Nanyuki, Catholic Secretariat.
2. Bloland, P. B., Lackritz, E. M., Kazembe, P. N., Were, J. B. O., Steketee, R. & Campbell, C. C. (1993). Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases, 167, 932-937.
3. Breman, J. G. & Campbell, C. C. (1988). Combating severe malaria in African children. Bulletin of the World Health Organization, 66, 611-620.
4. Fadat, G., Le Bras, J., Hengy, C., Louis, J. P., Gimou, M. M. & Verdier, F. (1991). Efficacy of amodiaquine against chloroquine-resistant malaria in Cameroon. Lancet, 338, 1092.
5. Greenwood, B. M. (1990). Populations at risk. Parasitology Today, 6, 188.
6. Hagos, B., Khan, B., Ofulla, A. V. O., Kariuki, D. & Martin, S. K. (1993). Response of falciparum malaria to chloroquine and three second line antimalarial drugs in a Kenyan coastal school age population. East African Medical Journal, 70, 620-623.
7. Hengy, C., Gazin, P., Eberle, F., Jambou, R. & Louis, J. P. (1990). Evaluation de l'efficacité des amino-4 quinoleines en zone de chimioresistance: propositions de nouveaux schémas thérapeutiques. Médecine Tropicale, 50, 109-112.
8. Irare, S. G. M., Lemnge, M. M. M. & Mhina, J. I. K. (1991). Falciparum malaria fully cleared by amodiaquine, pyrimethamine-sulfadoxine and pyrimethamine-sulfalene in areas of chloroquine resistance in Dodoma, Tanzania. Tropical and Geographical Medicine, 43, 352-356.
9. Kenya MOH (1995). Malaria Prevention Strategy. Nairobi: Division of Vector Borne Disease, Ministry of Health.
10. Keuter, M., Sanders, J., Ronday, M., Veltkamp, S., Kamsteeg, H., Schouten, E., Khalumi, G., Ngwawe, W., Wetsteyn, J. C. F. M. & Brandling-Bennett, A. D. (1992). Parasitological, clinical and haematological response of children with Plasmodium falciparum to 4-aminoquinolines and pyrimethamine-sulfadoxine with quinine in western Kenya. Tropical and Geographical Medicine, 44, 1-8.
11. Laderman, C. (1975). Malaria and progress : some historical and ecological considerations. Social Science and Medicine, 9, 587-594.
12. Miller, K. D., Lobel, H. O., Satriale, E. F., Kuritsky, J. N., Stern, R. & Campbell, C. C. (1986). Severe cutaneous reactions among American travelers using pyrimethaminesulfadoxine (Fansidar) for malaria prophylaxis. American Journal of Tropical Medicine and Hygiene, 35, 451-458.
13. Müller, O., Boele van Hensbroek, M., Jaffar, S., Drakeley, C., Okorie, C., Joof, D., Pinder, M. & Greenwood, B. M. (1996). A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulfadoxine in Gambian children with uncomplicated malaria. Tropical Medicine and International Health, 1, 124-132.
14. Nevill, C. G., Some, E. S., Mung'ala, V. O., Mutemi, W., New, L., Marsh, K., Lengeler, C. & Snow, R. W. (1996). Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast. Tropical Medicine and International Health, 1, 139-146.
15. Olliaro, P., Nevill, C., Le Bras, J., Ringwald, P., Mussano, P., Garner, P. & Brasseur, P. (1996). Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet, 348, 1196-1201.
16. Onyiorah, E., Boele van Hensbroek, M., Jah, M. S. & Greenwood, B. (1996). Early clinical failures after pyrimethaminesulfadoxine treatment of uncomplicated falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 307-308.
17. Phillips-Howard, P. A. & West, L. J. (1990). Serious adverse drug reactions to pyrimethamine-sulphadoxine, pyrimethamine-dapsone and to amodiaquine in Britain. Journal of the Royal Society of Medicine, 83, 82-85.
18. Rieckmann, K. H. (1990). Monitoring the response of malaria infections to treatment. Bulletin of the World Health Organization, 68, 759-760.
19. Ter Kuile, F. O., Nosten, F., Luxemburger, C., Phaipun, L., Chongsuphajaisiddhi, T. & White, N. J. (1994). Monitoring the therapeutic response to antimalarials: a classification of mefloquine efficacy. In: Mefloquine, Halofantrine and Artesunate in the Treatment of Uncomplicated Falciparum Malaria in a Multi-Drug Resistant Area, Ter Kuile, F. O. PhD thesis, University of Amsterdam, Amsterdam, The Netherlands.
20. Watkins, W. M. & Mosobo, M. (1993). Treatment of Plasmodium falciparum malaria with pyrimethamine-sulfadoxine: selective pressure for resistance is a function of long elimination half-life. Transactions of the Royal Society of Tropical Medicine and Hygiene, 87, 75-78.